13F 机构持仓

Krensavage Asset Management, LLC

NEW YORK NY · SEC CIK 0001609251

2026Q22026Q1 更早 9 个季度 🔒
$2.63亿2026Q2 申报市值
18持仓数
89.4%前十大占比 · 第一大 15.9%
0 / 2新建仓 / 清仓
申报市值走势$2.63亿2026Q2
26Q126Q2

付费方案可看全部 11 个季度的走势 🔒

前十大持仓 占组合比例

ENTA 15.9%
JAZZ 15.4%
UTHR 14.3%
BMRN 11.4%
EXEL 7.7%
ABT 6.9%
SNY 5.3%
SUPERNUS PHARM 5.0%
RARE 5.0%
VNDA 2.7%

2026Q2 买入最多 按季末市值估算

ABT 加仓+$1,769.43万
EMBC 加仓+$130.39万
REGN 加仓+$124.70万
ARDX 加仓+$17.61万

2026Q2 卖出最多 按季末市值估算

SUPN 清仓-$1,034.90万
UTHR 减仓-$812.74万
ALKS 清仓-$381.30万
EXEL 减仓-$244.84万

2026Q2 持仓明细 点表头排序

导出 CSV 🔒
代码名称市值 ▼占比股数变动股数变动估算买卖额操作
ENTA ENANTA PHARMACEUTICALS INC $4,178.80万15.88%2,866,138 00.0% — 不变
JAZZ JAZZ PHARMACEUTICALS PLC $4,043.90万15.36%167,816 00.0% — 不变
UTHR UNITED THERAPEUTICS CORP $3,753.90万14.26%69,282 -15,000-17.8% -$812.74万 减仓
BMRN BIOMARIN PHARMACEUTICAL INC $3,002.80万11.41%524,786 00.0% — 不变
EXEL EXELIXIS INC $2,016.90万7.66%370,693 -45,000-10.8% -$244.84万 减仓
ABT ABBOTT LABORATORIES $1,814.80万6.89%200,000 195,0003,900.0% $1,769.43万 加仓
SNY SANOFI-ADR $1,382.00万5.25%323,946 00.0% — 不变
— SUPERNUS PHARMACEUTICALS INC $1,305.40万4.96%280,681 00.0% — 不变
RARE ULTRAGENYX PHARMACEUTICAL IN $1,305.10万4.96%390,879 00.0% — 不变
VNDA VANDA PHARMACEUTICALS INC $722.40万2.74%1,180,388 00.0% — 不变
BNTX BIONTECH SE-ADR $553.90万2.10%59,523 00.0% — 不变
GSK GSK PLC-SPON ADR $507.10万1.93%96,729 00.0% — 不变
BIIB BIOGEN INC $432.10万1.64%20,000 00.0% — 不变
REGN REGENERON PHARMACEUTICALS $374.10万1.42%6,000 2,00050.0% $124.70万 加仓
EMBC EMBECTA CORP $370.10万1.41%1,135,340 400,00054.4% $130.39万 加仓
ARDX ARDELYX INC $272.60万1.04%534,523 34,5236.9% $17.61万 加仓
INMD INMODE LTD $176.80万0.67%120,942 00.0% — 不变
EOLS EVOLUS INC $109.60万0.42%157,985 00.0% — 不变
SUPN INDIVIOR PHARMACEUTICALS INC $00.00%0 -339,532-100.0% -$1,034.90万 清仓
ALKS ALKERMES PLC $00.00%0 -107,822-100.0% -$381.30万 清仓